Antibiogram of Urinary Enterococcus isolates from a tertiary care hospital.

PURPOSE: Urinary tract infection (UTI) is one of the serious infections caused by enterococci. VancomycinResistant Enterococci (VRE), is a persevering clinical problem globally. This study aims to detect high-level aminoglycoside and vancomycin resistance in uropathogenic Enterococcus spp. METHODOLOGY: A total of 75 clinically relevant Enterococcus spp. grown from urine samples, were collected following convenience non-random sampling method. Identified by standard biochemical tests and susceptibility to antibiotics was studied by Kirby Bauer's disc diffusion method. The MIC of vancomycin was detected by agar dilution test. Van A, and Van B genes in VREs were detected by PCR. RESULTS: Among the 75 Enterococcal isolates, 43 (57.3%) were E.faecalis, 12 (16%) were E.faecium, six (8%) each were E.pseudoavium and E.casseliflavus, five (6.66%) were E.dispar and three (4%) were E.durans. E.faecalis (n=19) and E.faecium (n=3) were resistant to High Level Streptomycin (HLS). E.faecalis (n=21) and E.faecium (n=6) were resistant to High Level Gentamicin (HLG). Four (9.3%) E.faecalis were vancomycin-resistant, of which three were of Van A, and one was both Van A and Van B genotype. CONCLUSION: Isolation of high level aminoglycoside resistant (HLAR) Enterococci is a challenge for the treating physician because aminoglycoside cannot be used in combination with glycopeptide or ampicillin for such isolates. The occurrence of HLAR, Van A and Van B VRE genotypes is a cause of concern as they may transfer drug resistance genes to other bacterial isolates, thus leading to limited therapeutic options.